20,000+ Scientists & Academics
4,000+ Scientific disciplines
20,000+ Projects posted
Trusted by 3,200+ businesses
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Contact
★★★★★
☆☆☆☆☆
USD 70 /hr
Hire Dr. Mehdi Javanbakht
United Kingdom
USD 70 /hr

I hold a Ph.D. in Health Economics and have over 15 years of experience in academia and industry.

Profile Summary
Subject Matter Expertise
Services
Scientific consulting Technical consulting, Market research, Marketing & communication
Scientific writing White paper, Grant proposal, Journal article, Review article, Clinical trial documents, Marketing content
Data science & analysis Simple data analysis, Complex data analysis, Statistical analysis, Algorithm design, Predictive modelling, Product design & development, Data visualization, Data processing, Data insights, Statistical review of research data
Academic research Qualitative research, Internet research, Systematic reviews and meta-analysis, Review article, Evidence-based answers, Secondary data compilation, Statistical review of research data, Literature search
Work Experience

CEO

Optimax Access

August 2017 - Present

Senior Consultant

Parexel

January 2016 - Present

Research fellow

University of Aberdeen

December 2013 - November 2015

Faculty Memeber

SUMS

September 2008 - November 2013

Education

PhD Health Economics

IUMS

February 2010 - November 2013

MSc Health Economics

IUMS

September 2006 - September 2008

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Javanbakht, M., Azuara-Blanco, A., Burr, J.M., Ramsay, C., Cooper, D., Cochran, C., Norrie, J., Scotland, G.(2017). Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: An economic evaluation based on data from the EAGLE trial . BMJ Open. 7. (1).
Vos, T., Allen, C., Arora, M., Barber, R.M., Bhutta, Z.A., Brown, A., Carter, A., Casey, D.C., Charlson, F.J., Chen, A.Z., et al.(2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1545-1602.
Kassebaum, N.J., Barber, R.M., Bhutta, Z.A., Dandona, L., Gething, P.W., Hay, S.I., Kinfu, Y., Larson, H.J., Liang, X., Lim, S.S., et al.(2016). Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1775-1812.
Haghighat, S., Akbari, M.E., Yavari, P., Javanbakht, M., Ghaffari, S.(2016). Cost-effectiveness of three rounds of mammography breast cancer screening in iranian women . Iranian Journal of Cancer Prevention. 9. (1). p. 1-8.
Scotland, G., McKeigue, P., Philip, S., Leese, G.P., Olson, J.A., Looker, H.C., Colhoun, H.M., Javanbakht, M.(2016). Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland . Diabetic Medicine. 33. (7). p. 886-895.
Yazdani-Bakhsh, R., Javanbakht, M., Sadeghi, M., Mashaiekhi, A., Ghaderi, H., Rabiei, K.(2016). Comparison of health-related quality of life after percutaneous coronary intervention and coronary artery bypass surgery . ARYA Atherosclerosis. 12. (3).
Forouzanfar, M.H., Afshin, A., Alexander, L.T., Anderson, H.R., Bhutta, Z.A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F.J., et al.(2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1659-1724.
Wang, H., Bhutta, Z.A., Coates, M.M., Coggeshall, M., Dandona, L., Diallo, K., Franca, E.B., Fraser, M., Fullman, N., Gething, P.W., et al.(2016). Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1725-1774.
Lim, S.S., Allen, K., Bhutta, Z.A., Dandona, L., Forouzanfar, M.H., Fullman, N., Gething, P.W., Goldberg, E.M., Hay, S.I., Holmberg, M., et al.(2016). Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1813-1850.
Keshavarz, K., Kebriaeezadeh, A., Alavian, S.M., Sari, A.A., Hemami, M.R., Lotfi, F., Meshkini, A.H., Javanbakht, M., Keshvari, M., Nikfar, S.(2016). A cost-utility and cost-effectiveness analysis of different oral antiviral medications in patients with HBeAg-negative chronic hepatitis B in Iran: An economic microsimulation decision model . Hepatitis Monthly. 16. (9).
Azuara-Blanco, A., Burr, J., Ramsay, C., Cooper, D., Foster, P.J., Friedman, D.S., Scotland, G., Javanbakht, M., Cochrane, C., Norrie, J.(2016). Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial . The Lancet. 388. (10052). p. 1389-1397.
Khalil, I., Colombara, D.V., Forouzanfar, M.H., Troeger, C., Daoud, F., Moradi-Lakeh, M., El Bcheraoui, C., Rao, P.C., Afshin, A., Charara, R., et al.(2016). Burden of diarrhea in the eastern mediterranean region, 1990-2013: Findings from the global burden of disease study 2013 . American Journal of Tropical Medicine and Hygiene. 95. (6). p. 1319-1329.
Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., Carter, A., Casey, D.C., Charlson, F.J., Chen, A.Z., Coates, M.M., et al.(2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1459-1544.
Wang, H., Wolock, T.M., Carter, A., Nguyen, G., Kyu, H.H., Gakidou, E., Hay, S.I., Mills, E.J., Trickey, A., Msemburi, W., et al.(2016). Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 . The Lancet HIV. 3. (8). p. e361-e387.
Javanbakht, M., Keshtkaran, A., Shabaninejad, H., Karami, H., Zakerinia, M., Delavari, S.(2015). Comparison of blood transfusion plus chelation therapy and bone marrow transplantation in patients with β-thalassemia: Application of SF-36, EQ-5D, and visual analogue scale measures . International Journal of Health Policy and Management. 4. (11). p. 733-740.
Javanbakht, M., Moradi-Lakeh, M., Yaghoubi, M., Esteghamati, A., Ghanaie, R.M., Mahmoudi, S., Shamshiri, A.-R., Zahraei, S.M., Baxter, L., Shakerian, S., et al.(2015). Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran . Vaccine. 33. (S1). p. A192-A200.
Javanbakht, M., Bakhsh, R.Y., Mashayekhi, A., Ghaderi, H., Sadeghi, M.(2014). Coronary bypass surgery versus percutaneous coronary intervention: Cost-effectiveness in Iran: A study in patients with multivessel coronary artery disease . International Journal of Technology Assessment in Health Care. 30. (4). p. 366-373.
Javanbakht, M., Mirahmadizadeh, A., Mashayekhi, A.(2014). The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis c virus among illicit drug users: A modeling study . Iranian Red Crescent Medical Journal. 16. (2).
Keshtkaran, A., Mirahmadizadeh, A., Heidari, A., Javanbakht, M.(2014). Cost-effectiveness of Methadone Maintenance Treatment in prevention of HIV among drug users in Shiraz, south of Iran . Iranian Red Crescent Medical Journal. 16. (1).
Hatam, N., Shirvani, S., Javanbakht, M., Askarian, M., Rastegar, M.(2013). Cost-utility analysis of neonatal screening program, Shiraz university of medical sciences, Shiraz, Iran, 2010 . Iranian Journal of Pediatrics. 23. (5). p. 493-500.
Alavian, S.-M., Mirahmadizadeh, A., Javanbakht, M., Keshtkaran, A., Heidari, A., Mashayekhi, A., Salimi, S., Hadian, M.(2013). Effectiveness of methadone maintenance treatment in prevention of hepatitis C virus transmission among injecting drug users . Hepatitis Monthly. 13. (8).
Keshtkaran, A., Javanbakht, M., Salavati, S., Mashayekhi, A., Karimi, M., Nuri, B.(2013). Cost-utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients . Transfusion. 53. (8). p. 1722-1729.
Hatam, N., Pourmohammadi, K., Keshtkaran, A., Javanbakht, M., Askarian, M.(2012). Factors affecting efficiency of social security hospitals in Iran: Data envelopment analysis . HealthMED. 6. (6). p. 1961-1968.
Javanbakht, M., Abolhasani, F., Mashayekhi, A., Baradaran, H.R., Jahangiri noudeh, Y.(2012). Health Related Quality of Life in Patients with Type 2 Diabetes Mellitus in Iran: A National Survey . PLoS ONE. 7. (8).
Javanbakht, M., Baradaran, H.R., Mashayekhi, A., Haghdoost, A.A., Khamseh, M.E., Kharazmi, E., Sadeghi, A.(2011). Cost-of-illness analysis of type 2 diabetes mellitus in Iran . PLoS ONE. 6. (10).